After Idenix: The Next Four Biotech Buyout Candidates
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at one stage or another and that could be the next takeover targets.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 288Large Cap Biotech Stocks to Buy Leading the Comeback Rally
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks to buy…
As GW Pharma Gets Fast Track, Is FDA More Open to Medical Marijuana?
GW Pharmaceuticals was one of the stocks surging on Friday, on news that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation status to the company's Epidiolex.
Halozyme Gets New Hope for Shareholders, and for Pancreatic Cancer Patients
Halozyme Therapeutics saw its stock surge on Thursday on news reports that the FDA has removed its clinical hold on patient enrollment and dosing of in the certain ongoing Phase 2 trials.
Four Top Medical Device Stocks That Are Takeover Candidates
Here are four top medical device makers that the Leerink team thinks make sense as potential takeover candidates, but also have more than enough merit to stand on their own.
UnitedHealth Delivers Healthy Dividend Hike and Major Stock Buyback Plan
UnitedHealth Group must be doing OK. The largest health insurer has announced a dividend hike and a new share buyback plan.
Top Biotech Stocks to Buy According to Portfolio Managers
A new research report from Cowen suggests that biotech investors appear to be looking forward to what they describe as a "return to normalcy" following the roller coaster ride of early 2014.
Analyst Cancer and Biotech Stock Picks From ASCO
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest health care conference is…
Valeant Offers Even More for Botox-Maker Allergan
ThinkstockCanada-based Valeant Pharmaceuticals Inc. (NYSE: VRX) has raised its offer for Allergan Inc. (NYSE: AGN) for the second time this week. The latest offer, announced just minutes ago includes $72 a share and 0.83…
Analyst Stocks to Buy for an Aging America
ThinkstockThe United States is not alone as our population ages. We join Japan and several other developed nations with a larger percentage of the population growing older. Better diet, exercise and health care are…
Pfizer’s Real Issue: Identity Crisis Against Peers
Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance is that Pfizer may now simply be having an identity crisis.
BioCryst Crushes It on Rare Immune Disorder Drug Trial
BioCryst Pharmaceuticals broke higher Tuesday morning, following the company's announcement that its oral drug for hereditary angioedema met objectives established for its Phase 2a clinical trial.
Three Companies That Want to Cure Pancreatic Cancer
A new research report from Cowen cautions that progress on a cure for pancreatic cancer is slow, but steady. Drugs from three companies though have been favorably viewed by consultants.
Why You Buy Big Pharma If the Market Crashes
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy now.
Top Biotech Stocks for Cancer Cures From Cowen
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the top names…